Integral Ad Science Holding Corp.

NASDAQ:IAS

8.13 (USD) • At close May 20, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 134.066153.038133.528129.005114.53134.295120.331113.651106.092117.435101.343100.32889.242102.47279.01475.07566.95278.30759.96448.3254.042
Cost of Revenue 30.12633.33227.37327.09441.24142.84525.59923.81921.68221.89119.17118.13216.56116.38113.84612.92511.4212.41510.188.7569.155
Gross Profit 103.94119.706106.155101.91173.28991.4594.73289.83284.4195.54482.17282.19672.68186.09165.16862.1555.53265.89249.78439.56444.887
Gross Profit Ratio 0.7750.7820.7950.790.640.6810.7870.790.7960.8140.8110.8190.8140.840.8250.8280.8290.8410.830.8190.831
Reseach & Development Expenses 19.717.54616.8417.48717.97819.05617.21121.1115.52922.2819.45917.62416.98719.46514.60920.17612.76912.82211.10712.72612.336
General & Administrative Expenses 26.19624.3125.34824.67921.3825.96122.61142.33920.72323.57220.1519.13716.76921.52516.08933.0448.54710.8376.8637.9467.64
Selling & Marketing Expenses 32.12830.75330.14429.57231.82530.42329.60431.70226.2628.32528.1926.69123.05723.45419.57427.26816.54517.37913.51916.75418.37
SG&A 58.32455.06355.49254.25153.07955.3352.21574.04146.98351.89748.3445.82839.82644.97935.66360.31225.09228.21620.38224.726.01
Other Expenses 14.46521.58413.63616.02416.64914.09216.10512.8912.82512.8116.98112.5112.45817.18816.114.60314.39516.52316.43416.41316.338
Operating Expenses 92.48994.19385.96887.76271.05774.38683.453108.67275.33786.98880.41675.96269.27181.63266.37295.09152.25657.56147.92353.83954.684
Operating Income 11.45125.51320.18714.1492.23217.0649.201-18.2099.5897.31-2.3086.7463.41-2.141-1.204-32.9413.2768.3311.861-14.275-9.797
Operating Income Ratio 0.0850.1670.1510.110.0190.1270.076-0.160.090.062-0.0230.0670.038-0.021-0.015-0.4390.0490.1060.031-0.295-0.181
Total Other Income Expenses Net -0.072-0.571-1.325-1.536-1.926-2.489-3.109-3.221-3.417-3.1944.362-1.814-1.426-1.364-9.474-5.167-6.96-7.822-7.795-7.695-8.258
Income Before Tax 11.37924.94218.86212.613-1.38914.0226.092-21.436.1724.1162.0544.9321.984-3.505-10.678-38.108-3.6840.509-5.934-21.97-18.055
Income Before Tax Ratio 0.0850.1630.1410.098-0.0120.1040.051-0.1890.0580.0350.020.0490.022-0.034-0.135-0.508-0.0550.007-0.099-0.455-0.334
Income Tax Expense -3.3869.6712.7734.923-0.1343.85819.841-29.1073.026-7.3711.2872.9710.8251.317-0.898-3.045-0.912-2.46-1.486-5.519-3.611
Net Income 7.99315.27116.0897.69-1.25510.164-13.7497.6773.14611.4860.7671.9611.159-4.822-9.78-35.063-2.7722.969-4.448-16.451-14.444
Net Income Ratio 0.060.10.120.06-0.0110.076-0.1140.0680.030.0980.0080.020.013-0.047-0.124-0.467-0.0410.038-0.074-0.34-0.267
EPS 0.050.090.10.048-0.0080.064-0.0880.0490.020.0750.0050.010.008-0.032-0.064-0.26-0.0190.022-0.033-0.12-0.097
EPS Diluted 0.050.090.0980.047-0.0080.062-0.0880.0470.020.0740.0050.010.007-0.032-0.064-0.26-0.0190.022-0.033-0.12-0.097
EBITDA 20.99842.44736.4331.22117.31231.65725.306-4.68821.89820.1221.35418.74415.86815.04711.175-18.33817.67124.85418.2952.1386.541
EBITDA Ratio 0.1570.2770.2730.2420.1510.2360.21-0.0410.2060.1710.2110.1870.1780.1470.141-0.2440.2640.3170.3050.0440.121